Danish pharmaceutical giant Novo Nordisk has confirmed a cyberattack in which threat actors gained unauthorized access to internal IT systems, exfiltrating pseudonymized patient data from clinical trials and, according to the alleged attackers, a trove of proprietary AI model assets. Novo Nordisk disclosed the incident on June 11, 2026, stating...
Read the full article at the source.
Comments (0)
No comments yet. Be the first to comment!